An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients

Stopped This study was terminated early due to recruitment difficulties. There were no safety concerns.

Conditions

• Gastroesophageal Reflux Disease

Interventions

• DRUG: SPD557
• DRUG: placebo

Sponsor

Shire